Header Logo

Connection

Theodore Friedman to Rats

Back to Details
This is a "connection" page, showing publications Theodore Friedman has written about Rats.
Theodore Friedman
Connection Strength
0.807
Rats
  1. Morphine treatment selectively regulates expression of rat pituitary POMC and the prohormone convertases PC1/3 and PC2. Peptides. 2013 Sep; 47:99-109.
    View in: PubMed
    Score: 0.099
  2. Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: implications for understanding the "switch" to opiate addiction. Neuroscience. 2008 Oct 15; 156(3):788-99.
    View in: PubMed
    Score: 0.070
  3. Cellular colocalization and coregulation between hypothalamic pro-TRH and prohormone convertases in hypothyroidism. Am J Physiol Endocrinol Metab. 2007 Jan; 292(1):E175-86.
    View in: PubMed
    Score: 0.061
  4. Regulation of regional expression in rat brain PC2 by thyroid hormone/characterization of novel negative thyroid hormone response elements in the PC2 promoter. Am J Physiol Endocrinol Metab. 2005 Jan; 288(1):E236-45.
    View in: PubMed
    Score: 0.055
  5. Thyroid hormone regulation of prohormone convertase 1 (PC1): regional expression in rat brain and in vitro characterization of negative thyroid hormone response elements. J Mol Endocrinol. 2004 Aug; 33(1):21-33.
    View in: PubMed
    Score: 0.053
  6. Prohormone convertase 2 enzymatic activity and its regulation in neuro-endocrine cells and tissues. Regul Pept. 2003 Feb 28; 110(3):197-205.
    View in: PubMed
    Score: 0.048
  7. Up-regulation of splenic prohormone convertases PC1 and PC2 in diabetic rats. Regul Pept. 2001 Dec 15; 102(2-3):135-45.
    View in: PubMed
    Score: 0.044
  8. Regulation of prohormone convertase 1 (PC1) by thyroid hormone. Am J Physiol Endocrinol Metab. 2001 Jan; 280(1):E160-70.
    View in: PubMed
    Score: 0.041
  9. Interactions between the prohormone convertase 2 promoter and the thyroid hormone receptor. Endocrinology. 2000 Sep; 141(9):3256-66.
    View in: PubMed
    Score: 0.040
  10. Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats. J Clin Invest. 2000 Apr; 105(7):955-65.
    View in: PubMed
    Score: 0.039
  11. Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines. Mol Cell Endocrinol. 1999 Dec 20; 158(1-2):143-52.
    View in: PubMed
    Score: 0.039
  12. Processing of pro-opiomelanocortin in GH3 cells: inhibition by prohormone convertase 2 (PC2) antisense mRNA. Mol Cell Endocrinol. 1996 Jan 15; 116(1):89-96.
    View in: PubMed
    Score: 0.029
  13. In vitro processing of proopiomelanocortin by recombinant PC1 (SPC3). Endocrinology. 1994 Sep; 135(3):854-62.
    View in: PubMed
    Score: 0.027
  14. Adolescence is a period of development characterized by short- and long-term vulnerability to the rewarding effects of nicotine and reduced sensitivity to the anorectic effects of this drug. Behav Brain Res. 2013 Nov 15; 257:275-85.
    View in: PubMed
    Score: 0.025
  15. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase. J Neurochem. 1986 Apr; 46(4):1231-9.
    View in: PubMed
    Score: 0.015
  16. Thyroid hormones selectively regulate the posttranslational processing of prothyrotropin-releasing hormone in the paraventricular nucleus of the hypothalamus. Endocrinology. 2006 Jun; 147(6):2705-16.
    View in: PubMed
    Score: 0.015
  17. Evidence for regulation of a thyrotropin-releasing hormone degradation pathway in GH3 cells. Endocrinology. 1986 Feb; 118(2):562-6.
    View in: PubMed
    Score: 0.015
  18. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum. Biochem Biophys Res Commun. 1985 Oct 30; 132(2):787-94.
    View in: PubMed
    Score: 0.014
  19. Glucose dependence of the regulated secretory pathway in alphaTC1-6 cells. Endocrinology. 2005 Oct; 146(10):4514-23.
    View in: PubMed
    Score: 0.014
  20. Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone. J Clin Invest. 2004 Aug; 114(3):357-69.
    View in: PubMed
    Score: 0.013
  21. Peptide-degrading enzymatic activities in GH3 cells and rat anterior pituitary homogenates. Endocrinology. 1984 Apr; 114(4):1407-12.
    View in: PubMed
    Score: 0.013
  22. The hypothalamic-pituitary-adrenal axis of prairie voles (Microtus ochrogaster): evidence for target tissue glucocorticoid resistance. Gen Comp Endocrinol. 1997 Apr; 106(1):48-61.
    View in: PubMed
    Score: 0.008
  23. Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J Clin Endocrinol Metab. 1996 Mar; 81(3):1046-50.
    View in: PubMed
    Score: 0.007
  24. Pro-thyrotropin-releasing hormone processing by recombinant PC1. J Neurochem. 1995 Dec; 65(6):2462-72.
    View in: PubMed
    Score: 0.007
  25. Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. Endocrinology. 1995 Oct; 136(10):4650-8.
    View in: PubMed
    Score: 0.007
  26. Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary. J Clin Invest. 1993 Aug; 92(2):961-8.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.